Abstract
Cancer fatalism is believed to be a major barrier for cancer screening in Black males. Therefore, the purpose of this study was to compare perceptions of prostate cancer (CaP) fatalism and predictors of CaP screening with Prostate Specific Antigen (PSA) testing between U.S.-born and Caribbean-born Black males. The Powe Fatalism Inventory and the Personal Integrative Model of CaP Disparity Survey were used to collect the following data from males in South Florida. Multivariate logistic regression models were constructed to examine the statistically significant predictors of CaP screening. A total of 211 U.S.-born and Caribbean-born Black males between ages 39–75 were recruited. Nativity was not a significant predictor of CaP screening with PSA testing within the last year (Odds ratio [OR] = 0.80, 95 % confidence interval [CI] = 0.26, 2.48, p = 0.70). Overall, higher levels of CaP fatalism were not a significant predictor of CaP screening with PSA testing within the last year (OR = 1.37, 95 % CI = 0.48, 3.91, p = 0.56). The study results suggest that nativity did not influence CaP screening with PSA testing. However, further studies are needed to evaluate the association between CaP screening behavior and levels of CaP fatalism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Cancer Society. Cancer facts and figures 2012. Atlanta, GA: American Cancer Society; 2012.
Jones R, Steeves R, Williams I. How African American men decide whether or not to get prostate cancer screening. Cancer Nurs. 2009;32(2):166–72.
American Cancer Society. Cancer facts and figures for African Americans 2009–2010. Atlanta, GA: American Cancer Society; 2009.
Brett AS, Ablin RJ. Prostate cancer screening—what the U.S. preventive services task force left out. N Engl J Med. 2011;365(21):1949–51.
Hoffman RM. Screening for prostate cancer. N Engl J Med. 2011;365(21):2013–9.
McNaughton-Collins MF, Barry MJ. One man at a time—resolving the PSA controversy. N Engl J Med. 2011;365(21):1951–3.
Schroder FH. Stratifying risk—the U.S. preventive services task force and prostate cancer screening. N Engl J Med. 2011;365(21):1953–5.
Lin K, Croswell JM, Koening H, Lam C, Maltz A. Prostate-specific antigen-based for prostate cancer: an evidence update for the U.S. Preventive task force. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventative services task force recommendation statement draft. Rockville, MD: U.S. Preventive Services Task Force; 2011.
Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. Screening for prostate cancer: a review of the evidence for the U.S. preventive services task force. Ann Intern Med. 2011;155:762–71.
Wolf A, Wender R, Etzioni R, Thompson I, D’Amico A, Volk R, et al. American cancer society guideline for early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98.
American Urological Association. Prostate-specific antigen best practice statement: 2009 update. Linthicum, MD: American Urological Association; 2009.
Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD. African–American men’s perceptions about prostate cancer: implications for designing educational interventions. Soc Sci Med 2007;2189–2200.
West C. Race matter. Boston, Massachusetts: Beacon Press; 1993.
Morgan P, Tyler I, Fogel J. Fatalism revisited. Semin Oncol NURS. 2008;24(4):237–45.
Powe BD, Johnson A. Fatalism among African Americans: philosophical perspectives. J Relig Health. 1995;34(2):119–25.
Odedina FT, Dagne G, Pressey S, Odedina O, Emanuel F, Scrivens J, et al. prostate cancer health and cultural beliefs of black men: the Florida prostate cancer disparity project. Infect Agent Cancer. 2011;6(Suppl 2):S10.
Odedina F, Dagne G, Larose-Pierre M, Scrivens J, Emanuel F, Adams A, et al. Within-group differences between native-born and foreign-born black men on prostate cancer risk reduction and early detection practices. J Immigr Minor Health. 2011;13(6):996–1004.
Magnus M. Prostate cancer knowledge among multiethnic black men. J Nati Med Assoc. 2004;96(5):650–6.
Jayadevappa R, Malkowicz SB, Chhatre S, Gallo S, Schwartz S. Racial and ethnic variation in health resources use and cost for prostate cancer. BJU Int. 2010;106:802–8.
Shavers VL, Underwood W, Moser RP. Race/ethnicity and the perception of the risk of developing prostate cancer. Am J Prev Med. 2009;37(1):64–7.
Gonzalez J, Consedine N, McKiernan J, Spencer B. Barrier to the initiation and maintenance of prostate specific antigen screening in black American and afro-Caribbean men. J Urol. 2008;180:2403–8.
Powe B. Fatalism among elderly African American: effects on colorectal cancer screening. Cancer Nurs. 1995;18(5):385–92.
Jany Y, Kim G, Chiriboga D, Kallimanis B. A Bidimensional model of acculturation for Korean American older adults. J Aging Stud. 2007;21(3):267–75.
Weinrich S, Seger R, Miller B, Davis C, Kim S, Wheeler C, et al. Knowledge of the limitation associated with prostate cancer screening among low-income men. Cancer Nurs. 2004;27(6):442–51.
Acknowledgments
The authors would like to thank Krystle I. Cobran, JD, MPP and Vickie L. Shavers, PhD for their excellent technical assistance. This study was partially supported by The Agency for Healthcare Research and Quality Grant R24 HS11673-01A1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cobran, E.K., Wutoh, A.K., Lee, E. et al. Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-Born and Caribbean-Born Black Males. J Immigrant Minority Health 16, 394–400 (2014). https://doi.org/10.1007/s10903-013-9825-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10903-013-9825-5